MK-0354產品描述:MK-0354 is a partial agonist of GPR109a receptor, for hGPR109a/ mGPR109a with EC50 of 1.65/1.08 μM, showed no activation of GPR109b.IC50 value: 1.65 μM (EC50, for hGPR109a), 1.08 μM (EC50, for mGPR109a) [1]Target: GPR109ain vitro: MK-0354 demonstrated clear and statistically significant partial agonism in the cAMP assays for both the mouse and human receptors with efficacy approximately 60-70% of that of either nicotinic acid or β-hydroxy butyrate, a putative physiologically relevant ligand for hGPR109a, in the same assay platform. In addition, MK-0354 showed no activation of GPR109b in the cAMP assay at any concentration up to 100 μM. Following these interesting observations, we then prepared a number of other 5,5-fused pyrazoles analogous to those that showed receptor activity in our earlier studies. MK-0354 appeared to be somewhat unique among the members of the pyrazole tetrazole series in having reasonable receptor activity.[1]in vivo: MK-0354 retained the plasma free fat 公司介紹:MedChemExpress(MCE)專注于各種抑制劑、激動劑、API及化合物庫,總部位于美國新澤西,分別在瑞典和上海設有歐洲區(qū)子公司和亞洲區(qū)總代理,營銷網點遍及全球20多個國家地區(qū)。MCE經過多年努力已成為全球生物活性小分子領域的一流供應商, 產品涵蓋癌癥、神經科學、抗感染、表觀遺傳學等20個熱門研究領域,PI3K、MAPK等近千個細分靶點,超過4000個活性小分子化合物現貨,以及GPCR、API、離子通道等超過20種不同類型的化合物庫,同時提供從毫克到千克的專業(yè)定制合成服務。 MCE 對每批產品都進行嚴格的LCMS和NMR檢驗,其產品已被全球近萬名客戶廣泛使用并發(fā)表大量文章、專利; MCE 定期增加各領域熱門抑制劑、激動劑,不斷擴增已有化合物庫,以滿足最新的科研需求; 數千種產品在上海有充足備貨,24-48小時內送達客戶; 大量產品提供免費試用裝;已為全球多個知名企業(yè)、院校構建各種定制型化合物庫。 產品鏈接:www.medchemexpress.cn/mk-0354.html |
MK-0354研究進展
發(fā)布日期:2017-11-01 瀏覽次數:1
核心提示:a href=https://www.medchemexpress.com/MK-0354.htmlMK-0354/a產品描述:MK-0354 is a partial agonist of GPR109a receptor, f
- 下一篇:PF-04620110研究進展
- 上一篇:PF-3758309研究進展
行業(yè)動態(tài)
更多...
- ATN-161 (trifluoroacetat 11-06
- AZM475271研究進展 11-06
- AVN-944研究進展 11-06
- Ascomycin研究進展 11-06
- β-Lapachone研究進展 11-06
- Anidulafungin研究進展 11-06
- Amsacrine (hydrochloride 11-06
- Amsacrine研究進展 11-06
- Uramustine研究進展 11-06
- Exherin (trifluoroacetat 11-06